Our previous studies have reported that one of the FOXP2 polymorphisms, rs10447760 within the 5’ regulatory region, is associated with clinical outcomes and cognitive deficits in chronic schizophrenia (Rao et al., 2017; Lang et al., 2019). This evidence concerns the gene FOXP2 and Cognitive impairment.